High-throughput interrogation of programmed ribosomal frameshifting in human cells

Programmed ribosomal frameshifting is the controlled slippage of the translating ribosome to an alternative frame. This tightly regulated process is widely employed by human viruses such as HIV and SARS coronavirus and is critical for their life cycle and virulence. It is also utilized from yeast to...

Full description

Saved in:
Bibliographic Details
Published inbioRxiv
Main Authors Mikl, Martin, Pilpel, Yitzhak, Segal, Eran
Format Paper
LanguageEnglish
Published Cold Spring Harbor Cold Spring Harbor Laboratory Press 13.03.2020
Subjects
Antiviral agents
Clinical isolates
Gag protein
HIV
Human immunodeficiency virus
Learning algorithms
Life cycles
Virulence
Online AccessGet full text

Cover

More Information
Summary:Programmed ribosomal frameshifting is the controlled slippage of the translating ribosome to an alternative frame. This tightly regulated process is widely employed by human viruses such as HIV and SARS coronavirus and is critical for their life cycle and virulence. It is also utilized from yeast to human to implement a feedback control mechanism to regulate polyamine levels. Here, we developed a high-throughput, fluorescence-based approach to assess the frameshifting potential of a sequence. We designed and tested >12,000 sequences based on 15 viral and human frameshifting events, allowing us to elucidate the rules governing ribosomal frameshifting in a systematic way and to discover novel regulatory inputs based on amino acid properties and tRNA availability. We assessed the natural variation in HIV gag-pol frameshifting rates by testing >500 clinical isolates and identified subtype-specific differences as well as associations between viral load in patients and the optimality of gag-pol frameshifting rates. We further devised computational models that accurately predict frameshifting potential (up to auROC=0.93) and frameshifting rates (up to Pearson r=0.81) of novel variants, including subtle differences between HIV clinical isolates (r=0.60). Taken together, this systematic approach can contribute to the development of antiviral agents acting on programmed ribosomal frameshifting. Footnotes * We now focus exclusively on the extensive comparative analysis of programmed ribosomal frameshifting including the screening of HIV clinical isolates and the prediction of frameshifting potential and frameshifting rates (Figures 1, 2 and 4 in the previous version of the manuscript). We now provide additional controls and readouts (e.g. analysis of RNA expression levels and splicing) and substantially expanded our analyses (new Figures 1-6).
DOI:10.1101/469692